2.0
Oct 25, 2010
Former employee
Recommend
CEO approval
Business outlook
Pros
Great benefits, wealth of tools and training to do your job, reasonably stable company
Cons
Company stability in question with patent expiration and Roche take over. Even before this, advancement, outside of core biotech, correlated only with connections or whether you represented a desired demographic niche. Now, that's doubly true.